Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 3/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | PRNP | P04156 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3959212 | 0.87 | TNF (0.44) | L3MBTL1KDM4EALDH1A1MAPTNPC1 | |
| SCHEMBL3962337 | 0.87 | SERPINE1 (0.46) | STING1L3MBTL1KDM4EALDH1A1MAPT | |
| SCHEMBL13939956 | 0.86 | ALDH1A1 (0.42) | STING1L3MBTL1KDM4EALDH1A1MAPT | |
| SCHEMBL3967317 | 0.80 | MAPT (0.38) | STING1L3MBTL1KDM4EALDH1A1MAPT | |
| SCHEMBL13939979 | 0.77 | MAPT (0.42) | STING1ESR1L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL23787472 | 0.77 | NPC1 (0.60) | L3MBTL1KDM4EALDH1A1MAPTNPC1 | |
| SCHEMBL4071677 | 0.74 | HDAC1 (0.37) | L3MBTL1KDM4EALDH1A1MAPTNPC1 | |
| SCHEMBL22955153 | 0.71 | HDAC8 (0.43) | STING1ALDH1A1HDAC8 | |
| SCHEMBL3967322 | 0.70 | RAB9A (0.38) | STING1L3MBTL1KDM4EALDH1A1MAPT | |
| SCHEMBL21624241 | 0.70 | NPC1 (0.69) | L3MBTL1KDM4EALDH1A1MAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090023926-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2009-01-22 | — | — | US | disclosed |
| US-20090023926-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2009-01-22 | — | — | US | disclosed |
| US-20090023926-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2009-01-22 | — | — | US | disclosed |
| EP-1802630-A2 | TRITYL DERIVATIVES FOR ENHANCING MASS SPECTROMETRY | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006032893-A2 | TRITYL DERIVATIVES FOR ENHANCING MASS SPECTROMETRY | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2006-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023926-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | F3, TBCA, GYPA | STING1 3072/4885ESR1 4265/4885L3MBTL1 3578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.